Edwards Lifesciences Corp. (EW)
90.50
+0.72
(+0.80%)
USD |
NYSE |
Aug 24, 16:00
90.50
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Net Income (Quarterly) : 241.40M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 241.40M |
| March 31, 2026 | 380.70M |
| December 31, 2025 | 64.20M |
| September 30, 2025 | 292.30M |
| June 30, 2025 | 335.90M |
| March 31, 2025 | 363.60M |
| December 31, 2024 | 345.00M |
| September 30, 2024 | 362.10M |
| June 30, 2024 | 364.00M |
| March 31, 2024 | 324.90M |
| December 31, 2023 | 333.10M |
| September 30, 2023 | 334.90M |
| June 30, 2023 | 254.20M |
| March 31, 2023 | 340.50M |
| December 31, 2022 | 398.40M |
| September 30, 2022 | 343.50M |
| June 30, 2022 | 406.40M |
| March 31, 2022 | 373.60M |
| December 31, 2021 | 335.30M |
| September 30, 2021 | 340.10M |
| June 30, 2021 | 489.50M |
| March 31, 2021 | 338.20M |
| December 31, 2020 | 309.50M |
| September 30, 2020 | 325.20M |
| June 30, 2020 | -121.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 310.60M |
| December 31, 2019 | 280.20M |
| September 30, 2019 | 274.70M |
| June 30, 2019 | 242.30M |
| March 31, 2019 | 249.70M |
| December 31, 2018 | 7.00M |
| September 30, 2018 | 225.90M |
| June 30, 2018 | 282.70M |
| March 31, 2018 | 206.60M |
| December 31, 2017 | -2.80M |
| September 30, 2017 | 170.10M |
| June 30, 2017 | 186.10M |
| March 31, 2017 | 230.20M |
| December 31, 2016 | 158.50M |
| September 30, 2016 | 141.40M |
| June 30, 2016 | 126.60M |
| March 31, 2016 | 143.00M |
| December 31, 2015 | 140.70M |
| September 30, 2015 | 118.10M |
| June 30, 2015 | 112.70M |
| March 31, 2015 | 123.40M |
| December 31, 2014 | 109.20M |
| September 30, 2014 | 94.60M |
| June 30, 2014 | 547.00M |
| March 31, 2014 | 60.30M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Stryker Corp. | 1.276B |
| Intuitive Surgical, Inc. | 823.20M |
| Abbott Laboratories | 928.00M |
| Boston Scientific Corp. | 905.00M |
| Zimmer Biomet Holdings, Inc. | 199.60M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.741B |
| Total Expenses (Quarterly) | 1.499B |
| EPS Diluted (Quarterly) | 0.4188 |
| Enterprise Value | 48.33B |
| Gross Profit Margin (Quarterly) | 78.09% |
| Profit Margin (Quarterly) | 13.87% |
| Earnings Yield | 1.86% |
| Operating Earnings Yield | 3.53% |
| Normalized Earnings Yield | 2.618 |